Research Library

Curated Studies & Clinical Data

A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.

698Curated Studies
27Compounds Covered
9Clinical Trials
401Journals Referenced
STUDY

GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis

Bruna-Mejias A, Valenzuela-Fuenzalida JJ, Oyanedel G, et al.

Nutrients, 2026;18(11)

STUDY

Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report

Sato M, Takemura R, Yuki M, et al.

Journal of clinical medicine research, 2026;18(5):292-300

GLP-1 Semaglutide
STUDY

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data

Popa Ilie IR, Ghibu S, Butuca A, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(6)

GLP-1 Semaglutide tirzepatide
PRECLINICAL / IN VIVO

Impact of Semaglutide on Hippocampal Injury in a Streptozotocin-Induced Model of Alzheimer’s Disease

Stavrovskaya AV, Pavlova AK, Voronkov DN, et al.

Biomedicines, 2026;14(6)

Semaglutide
STUDY

Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control

Hemdev V, Abuzenah M, Alsaafin Q, et al.

Cureus, 2026;18(5):e109953

Semaglutide tirzepatide
STUDY

BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase

Jelińska J, Józwiak M, Szeleszczuk Ł, et al.

International journal of molecular sciences, 2026;27(11)

BPC-157
PRECLINICAL / IN VIVO

Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach

Smoday IM, Vukovic V, Oroz K, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(6)

STUDY

Prolonged Dysesthesia After Massive Accidental Semaglutide Overdose: A Case Report

Quarenghi M, Stanga A, Bergamaschi A

Journal of the American College of Emergency Physicians open, 2026;7(4):100427

GLP-1 Semaglutide
STUDY

Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance

Zambrano-Villacres R, Campuzano-Donoso M, Reytor-González C, et al.

Nutrients, 2026;18(11)

GLP-1
STUDY

Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans

Johnson AA, Sinclair DA

Frontiers in genetics, 2026;17:1836446

GLP-1 Semaglutide
PRECLINICAL / IN VIVO

Activation of GLP-1R ameliorates alcohol withdrawal induced anxiety-like behavior by regulating neuronal mitochondrial quality control

Wang Z, Zhao W, Chen X, et al.

Frontiers in pharmacology, 2026;17:1820128

Semaglutide
PRECLINICAL / IN VIVO

Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal Permeation with Sodium Caprate

Kim DH, Hwang SK, Yoon JH, et al.

Pharmaceutics, 2026;18(6)

Semaglutide
STUDY

Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH

Dinkov B

Biomedicines, 2026;14(6)

GLP-1 Semaglutide tirzepatide
PRECLINICAL / IN VIVO

Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury

Yıldırım AK, Demirtaş H, Özer A, et al.

Scientific reports, 2026

PRECLINICAL / IN VIVO

LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma

Zhang Y, Qian S, Yang Q, et al.

Cell death & disease, 2026

epitalon P21
PRECLINICAL / IN VIVO

Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide

Olson TE, Lloyd TS, Hamad CD, et al.

JOR spine, 2026;9(2):e70196

GLP-1 Semaglutide
IN VITRO

Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system

McGilvrey M, Chew S, Siddiqui MF, et al.

bioRxiv : the preprint server for biology, 2026

Semaglutide
STUDY

Lean Mass and Musculoskeletal Preservation in GLP-1-Based Obesity Treatment: Nutrition, Exercise, Supplementation, and Monitoring Strategies

Šantić R, Martinović L, Pavlović N, et al.

Metabolites, 2026;16(6)

GLP-1 Semaglutide tirzepatide
PRECLINICAL / IN VIVO

Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs

Mazzola J, Rosenfeld M, Tucker M, et al.

Research square, 2026

GHK-Cu P21
STUDY

Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study

Sumbul HE, Isik B, Mustan AG, et al.

Journal of clinical medicine, 2026;15(11)

Semaglutide

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.